Addex Therapeutics LtdADXNNASDAQ
Loading
Gross Profit Growth TrendStable
Percentile Rank87
3Y CAGR-2.3%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-2.3%/yr
Quarterly compound
Percentile
P87
Within normal range
vs 3Y Ago
0.9x
Contraction
Streak
2 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q3 2025 | 115.01% |
| Q2 2025 | 0.00% |
| Q1 2025 | -100.00% |
| Q4 2024 | -97.20% |
| Q3 2024 | -53.30% |
| Q2 2024 | -50.63% |
| Q1 2024 | 52.15% |
| Q4 2023 | -53.18% |
| Q3 2023 | -48.05% |
| Q2 2023 | 25.95% |
| Q1 2023 | -15.45% |
| Q4 2022 | 44.70% |
| Q3 2022 | 123.29% |
| Q2 2022 | -22.71% |
| Q1 2022 | -40.32% |
| Q4 2021 | -41.72% |
| Q3 2021 | -31.29% |
| Q2 2021 | 17.57% |
| Q1 2021 | -53.63% |
| Q4 2020 | 6578.04% |
| Q3 2020 | -96.83% |
| Q2 2020 | 1.71% |
| Q1 2020 | -18.64% |
| Q4 2019 | 143.12% |
| Q3 2019 | -628.05% |
| Q2 2019 | -30.79% |
| Q1 2019 | 207.17% |
| Q4 2018 | 17.87% |
| Q3 2018 | -145.67% |
| Q2 2018 | 0.00% |
| Q1 2018 | 371.84% |
| Q4 2017 | 0.00% |
| Q3 2017 | -31.14% |
| Q2 2017 | 0.00% |
| Q1 2017 | 27.62% |
| Q4 2016 | 0.00% |
| Q3 2016 | -63.78% |
| Q2 2016 | 0.00% |
| Q1 2016 | -503.56% |
| Q4 2015 | 0.00% |